» Articles » PMID: 31370252

Stimuli-Responsive Drug Release from Smart Polymers

Overview
Date 2019 Aug 3
PMID 31370252
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Over the past 10 years, stimuli-responsive polymeric biomaterials have emerged as effective systems for the delivery of therapeutics. Persistent with ongoing efforts to minimize adverse effects, stimuli-responsive biomaterials are designed to release in response to either chemical, physical, or biological triggers. The stimuli-responsiveness of smart biomaterials may improve spatiotemporal specificity of release. The material design may be used to tailor smart polymers to release a drug when particular stimuli are present. Smart biomaterials may use internal or external stimuli as triggering mechanisms. Internal stimuli-responsive smart biomaterials include those that respond to specific enzymes or changes in microenvironment pH; external stimuli can consist of electromagnetic, light, or acoustic energy; with some smart biomaterials responding to multiple stimuli. This review looks at current and evolving stimuli-responsive polymeric biomaterials in their proposed applications.

Citing Articles

Cancer theragnostics: closing the loop for advanced personalized cancer treatment through the platform integration of therapeutics and diagnostics.

Sergeeva O, Luo L, Guiseppi-Elie A Front Bioeng Biotechnol. 2025; 12:1499474.

PMID: 39898278 PMC: 11782185. DOI: 10.3389/fbioe.2024.1499474.


Therapeutic functions of medical implants from various material categories with integrated biomacromolecular systems.

Calais G, Garcia G, de Moura Junior C, Soares J, Lona L, Beppu M Front Bioeng Biotechnol. 2025; 12:1509397.

PMID: 39867472 PMC: 11757644. DOI: 10.3389/fbioe.2024.1509397.


Overcoming Challenges in Small-Molecule Drug Bioavailability: A Review of Key Factors and Approaches.

Wu K, Kwon S, Zhou X, Fuller C, Wang X, Vadgama J Int J Mol Sci. 2024; 25(23.

PMID: 39684832 PMC: 11642056. DOI: 10.3390/ijms252313121.


The Application of Nano Drug Delivery Systems in Female Upper Genital Tract Disorders.

van Staden D, Gerber M, Lemmer H Pharmaceutics. 2024; 16(11).

PMID: 39598598 PMC: 11597179. DOI: 10.3390/pharmaceutics16111475.


Advancements in Drug Delivery Systems for the Treatment of Sarcopenia: An Updated Overview.

Najm A, Moldoveanu E, Niculescu A, Grumezescu A, Beuran M, Gaspar B Int J Mol Sci. 2024; 25(19).

PMID: 39409095 PMC: 11476378. DOI: 10.3390/ijms251910766.


References
1.
Mohapatra A, Harris M, Levine D, Ghimire M, Jennings J, Morshed B . Magnetic stimulus responsive vancomycin drug delivery system based on chitosan microbeads embedded with magnetic nanoparticles. J Biomed Mater Res B Appl Biomater. 2017; 106(6):2169-2176. DOI: 10.1002/jbm.b.34015. View

2.
Davaran S, Ghamkhari A, Alizadeh E, Massoumi B, Jaymand M . Novel dual stimuli-responsive ABC triblock copolymer: RAFT synthesis, "schizophrenic" micellization, and its performance as an anticancer drug delivery nanosystem. J Colloid Interface Sci. 2016; 488:282-293. DOI: 10.1016/j.jcis.2016.11.002. View

3.
Ortiz de Solorzano I, Alejo T, Abad M, Bueno-Alejo C, Mendoza G, Andreu V . Cleavable and thermo-responsive hybrid nanoparticles for on-demand drug delivery. J Colloid Interface Sci. 2018; 533:171-181. DOI: 10.1016/j.jcis.2018.08.069. View

4.
Fan J, He Q, Liu Y, Zhang F, Yang X, Wang Z . Light-Responsive Biodegradable Nanomedicine Overcomes Multidrug Resistance via NO-Enhanced Chemosensitization. ACS Appl Mater Interfaces. 2016; 8(22):13804-11. PMC: 5233726. DOI: 10.1021/acsami.6b03737. View

5.
Zhou X, Guo L, Shi D, Duan S, Li J . Biocompatible Chitosan Nanobubbles for Ultrasound-Mediated Targeted Delivery of Doxorubicin. Nanoscale Res Lett. 2019; 14(1):24. PMC: 6335234. DOI: 10.1186/s11671-019-2853-x. View